TARS2 and cancer: Accordingly, CN gains were frequently detected (≥75%) in those chromosomal regions coding for the PSCA, SLURP1, NTSR1, CDH4, BAI1, TARS2, GML, OGFR and PTPRN2 genes, which have been described to be involved in cancer and/or pancreatic functions.